FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 118_S_2948.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2023-09-27.
What are the main provisions?
Key points include:
- Federal agencies must mandatorily acquire and maintain opioid overdose reversal medication (like Naloxone) in the workplace.
- All Federal agency employees must receive mandatory annual training on how to properly use these life-saving kits.
- Private employers will receive non-binding government guidance encouraging them to adopt similar kit acquisition and training programs.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Merkley, Jeff [D-OR].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.